CONJUGATES FOR THE PREVENTION OR TREATMENT OF NICOTINE ADDICTION

The present invention relates in part to nicotine-derived hapten-carrier conjugates of the formula (III): wherein m, n, W, -(spacer)-, X* and Y are as defined in the description. In certain embodiments, said nicotine-derived hapten-carrier conjugates can be used to prepare vaccines for the treatment...

Full description

Saved in:
Bibliographic Details
Main Authors PRYDE, DAVID CAMERON, STEAD, DAVID ROBERT, MERSON, JAMES RICHARD, MEHELIC, PAUL ROBERT, JONES, LYN HOWARD, BHATTACHARYA, KESHAB, GERVAIS, DAVID P, FINNEMAN, JARI ILMARI, DAVIS, HEATHER LYNN, MCCLUSKIE, MICHAEL JOHN, BROWN, ALAN DANIEL, PARSONS, ERIN KRISTEN, THORN, JENNIFER MARIE, ANASTASIOU, NICKOLAS, KOLHE, PARAG ASHOK
Format Patent
LanguageEnglish
French
Published 19.01.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates in part to nicotine-derived hapten-carrier conjugates of the formula (III): wherein m, n, W, -(spacer)-, X* and Y are as defined in the description. In certain embodiments, said nicotine-derived hapten-carrier conjugates can be used to prepare vaccines for the treatment and/or prevention of nicotine addiction.
Bibliography:Application Number: CA20112800882